Your browser doesn't support javascript.
loading
Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman, L; Giske, C G; Bruchfeld, J; Schön, T; Juréen, P; Ängeby, K.
Afiliación
  • Davies Forsman L; Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden lina.davies-forsman@karolinska.se.
  • Giske CG; Department of Clinical Microbiology, Karolinska University Hospital, Solna, Sweden Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Bruchfeld J; Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Schön T; Department of Medical Microbiology, Linköping University Hospital, Linköping, Sweden Department of Clinical Microbiology and Infectious Diseases, Kalmar County Hospital, Kalmar, Sweden.
  • Juréen P; Unit of Highly Pathogenic Bacteria, Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
  • Ängeby K; Department of Clinical Microbiology, Karolinska University Hospital, Solna, Sweden Department of Microbiology, The University of the West Indies, Kingston, Jamaica.
Antimicrob Agents Chemother ; 59(6): 3630-2, 2015.
Article en En | MEDLINE | ID: mdl-25824227

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tienamicinas / Ácido Clavulánico / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tienamicinas / Ácido Clavulánico / Mycobacterium tuberculosis / Antituberculosos Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article País de afiliación: Suecia